Maus A, Thompson C, Grebe S
J Endocr Soc. 2025; 9(3):bvaf015.
PMID: 39911521
PMC: 11791033.
DOI: 10.1210/jendso/bvaf015.
Lu Y, Zhao H, Liu C, Kuang Z, Li X
Front Oncol. 2025; 14():1426785.
PMID: 39777353
PMC: 11703863.
DOI: 10.3389/fonc.2024.1426785.
Ferraz C, Cunha G, de Oliveira M, Tenorio L, Cury A, Padovani R
Front Endocrinol (Lausanne). 2024; 15:1390743.
PMID: 39036050
PMC: 11257861.
DOI: 10.3389/fendo.2024.1390743.
Mouaden A, Guerrouj H, Ghfir I, Aouad N B
World J Nucl Med. 2023; 22(4):300-305.
PMID: 38152095
PMC: 10751120.
DOI: 10.1055/s-0043-1777692.
Baumgarten J, Happel C, Groener D, Staudt J, Bockisch B, Sabet A
Curr Oncol. 2022; 29(6):4012-4019.
PMID: 35735429
PMC: 9221990.
DOI: 10.3390/curroncol29060320.
Predictors of Response to Therapy Among Post Thyroidectomy Adult Filipino Patients with Papillary Thyroid Carcinoma Based on the 2015 American Thyroid Association Guidelines.
Santiago A, Isidro M, Parra J
J ASEAN Fed Endocr Soc. 2021; 36(2):161-166.
PMID: 34966200
PMC: 8666484.
DOI: 10.15605/jafes.036.02.18.
Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer.
Ponder M, Lamos E, Munir K
Case Rep Endocrinol. 2021; 2021:1152572.
PMID: 34840835
PMC: 8612797.
DOI: 10.1155/2021/1152572.
More sensitivity is always better: Measuring sub-clinical levels of serum thyroglobulin on a µLC-MS/MS system.
Shuford C, Johnson J, Thompson J, Holland P, Hoofnagle A, Grant R
Clin Mass Spectrom. 2021; 15:29-35.
PMID: 34820513
PMC: 8601006.
DOI: 10.1016/j.clinms.2020.01.001.
Multidisciplinary Diagnosis of Subcutaneous Soft Tissue Metastasis of Follicular Thyroid Carcinoma: A Case Report.
Wang Y, Nie F, Fang Q
Front Endocrinol (Lausanne). 2020; 11:235.
PMID: 32390944
PMC: 7188785.
DOI: 10.3389/fendo.2020.00235.
THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER - CLINICAL CONSIDERATIONS.
Prpic M, Franceschi M, Romic M, Jukic T, Kusic Z
Acta Clin Croat. 2019; 57(3):518-527.
PMID: 31168186
PMC: 6536288.
DOI: 10.20471/acc.2018.57.03.16.
Thyroid nodules and long-term follow-up among childhood cancer survivors who underwent hematopoietic stem cell transplantation.
Shimazaki S, Kazukawa I, Ishida M, Minagawa M
Clin Pediatr Endocrinol. 2018; 27(2):75-79.
PMID: 29662266
PMC: 5897582.
DOI: 10.1297/cpe.27.75.
Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
Wheeler S, Liu L, Blair H, Sivak R, Longo N, Tischler J
BMC Res Notes. 2017; 10(1):725.
PMID: 29221487
PMC: 5723050.
DOI: 10.1186/s13104-017-3050-6.
Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
Ernaga-Lorea A, Hernandez-Morhain M, Anda-Apinaniz E, Pineda-Arribas J, Migueliz-Bermejo I, Eguilaz-Esparza N
Clin Transl Oncol. 2017; 20(6):740-744.
PMID: 29071517
DOI: 10.1007/s12094-017-1782-3.
Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma.
Yang J, Maciel R, Nakabashi C, Janovsky C, Padovani R, Macellaro D
Arch Endocrinol Metab. 2017; 61(5):416-425.
PMID: 28977157
PMC: 10522253.
DOI: 10.1590/2359-3997000000285.
The Role of Intraoperative Thyroglobuline Level of Lymph Node in the Management of Papillary Thyroid Cancer (Determination of a Cutoff Point).
Kolahdouzan M, Sadeghi M, Kalidari B, Sanei B, Mostafapour E, Aminorroaya A
Adv Biomed Res. 2017; 6:99.
PMID: 28900610
PMC: 5583626.
DOI: 10.4103/abr.abr_145_16.
Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
Zhang Y, Xu D, Pan J, Yang Z, Chen M, Han J
Oncol Lett. 2017; 13(6):4252-4266.
PMID: 28599426
PMC: 5452941.
DOI: 10.3892/ol.2017.6028.
Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study.
Sarfo-Kantanka O, Sarfo F, Oparebea Ansah E, Yorke E, Akpalu J, Nkum B
BMC Endocr Disord. 2017; 17(1):2.
PMID: 28143459
PMC: 5286684.
DOI: 10.1186/s12902-016-0152-4.
Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients.
Yoon H, Kim S, O J, Seo Y, Lee Y, Kim H
Nucl Med Mol Imaging. 2015; 49(4):276-83.
PMID: 26550046
PMC: 4630323.
DOI: 10.1007/s13139-015-0361-1.
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A, Utratna M, ODwyer M, Joshi L, Kilcoyne M
Biomed Res Int. 2015; 2015:490531.
PMID: 26509158
PMC: 4609776.
DOI: 10.1155/2015/490531.
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y
Thyroid. 2015; 26(1):1-133.
PMID: 26462967
PMC: 4739132.
DOI: 10.1089/thy.2015.0020.
